{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:25:28Z","timestamp":1778617528006,"version":"3.51.4"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T00:00:00Z","timestamp":1709856000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["AZV NU20\\u201305-00320"],"award-info":[{"award-number":["AZV NU20\\u201305-00320"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.clim.2024.110170","type":"journal-article","created":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T00:19:05Z","timestamp":1709857145000},"page":"110170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Tumor-necrosis factor \u03b1-rich environment alters type-I interferon response to viral stimuli in patients with juvenile idiopathic arthritis by altering myeloid dendritic cell phenotype"],"prefix":"10.1016","volume":"262","author":[{"given":"Irena","family":"Zentsova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Klocperk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marketa","family":"Bloomfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena","family":"Kubesova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hana","family":"Malcova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dita","family":"Cebecauerova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rudolf","family":"Horvath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Sediva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuzana","family":"Parackova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2024.110170_bb0005","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/5045248","article-title":"Dendritic cells in systemic lupus erythematosus: from pathogenic players to therapeutic tools","volume":"2016","author":"Klarquist","year":"2016","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.clim.2024.110170_bb0010","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s00296-022-05136-x","article-title":"The second decade of anti-TNF-a therapy in clinical practice: new lessons and future directions in the COVID-19 era","volume":"42","author":"Evangelatos","year":"2022","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.clim.2024.110170_bb0015","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/intimm\/dxu102","article-title":"Anti-TNF therapy: past, present and future","volume":"27","author":"Monaco","year":"2015","journal-title":"Int. Immunol."},{"key":"10.1016\/j.clim.2024.110170_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12969-023-00798-8","article-title":"Efficacy and safety of TNF inhibitors in the treatment of juvenile idiopathic arthritis: a systematic literature review","volume":"21","author":"Horneff","year":"2023","journal-title":"Pediatr. Rheumatol."},{"issue":"1","key":"10.1016\/j.clim.2024.110170_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12969-021-00629-8","article-title":"Juvenile idiopathic arthritis: from aetiopathogenesis to therapeutic approaches","volume":"19","author":"Zaripova","year":"2021","journal-title":"Pediatr. Rheumatol."},{"key":"10.1016\/j.clim.2024.110170_bb0030","series-title":"Expanded Population of Low- Density Neutrophils in Juvenile Idiopathic Arthritis","first-page":"1","author":"Parackova","year":"2023"},{"key":"10.1016\/j.clim.2024.110170_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2022.109170","article-title":"Immunomodulation of neutrophils and platelets by TNF blockage in patients with juvenile idiopathic arthritis","volume":"245","author":"Parackova","year":"2022","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2024.110170_bb0040","first-page":"9","article-title":"Increased histone citrullination in juvenile idiopathic arthritis","author":"Parackova","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.clim.2024.110170_bb0045","series-title":"Anti-TNF-Alpha-Induced Lupus","first-page":"21","author":"De Bandt","year":"2019"},{"key":"10.1016\/j.clim.2024.110170_bb0050","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1084\/jem.20170412","article-title":"A multidimensional blood stimulation assay reveals immune alterations underlying systemic juvenile idiopathic arthritis","volume":"214","author":"Cepika","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2024.110170_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/ar3150","article-title":"Type I IFN and TNF\u03b1 cross-regulation in immune-mediated inflammatory disease: basic concepts and clinical relevance","volume":"12","author":"Cantaert","year":"2010","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.clim.2024.110170_bb0060","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1073\/pnas.0408506102","article-title":"Cross-regulation of TNF and IFN- in autoimmune diseases","volume":"102","author":"Palucka","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.clim.2024.110170_bb0065","doi-asserted-by":"crossref","first-page":"785","DOI":"10.4049\/jimmunol.1901358","article-title":"TNF-\u03b1 regulates human Plasmacytoid dendritic cells by suppressing IFN-\u03b1 production and enhancing T cell activation","volume":"206","author":"Psarras","year":"2021","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2024.110170_bb0070","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.immuni.2006.08.009","article-title":"Type I Inteferon gene induction by the interferon regulatory factor family of transcription factors","volume":"25","author":"Honda","year":"2006","journal-title":"Immunity."},{"key":"10.1016\/j.clim.2024.110170_bb0075","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/ni1303","article-title":"Innate immune recognition of viral infection","volume":"7","author":"Kawai","year":"2006","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2024.110170_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2020.01513","article-title":"The role of dendritic cells during infections caused by highly prevalent viruses","volume":"11","author":"Soto","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2024.110170_bb0085","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1084\/jem.20092140","article-title":"Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens","volume":"207","author":"Jongbloed","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2024.110170_bb0090","doi-asserted-by":"crossref","first-page":"5371","DOI":"10.1182\/blood-2006-08-038422","article-title":"Functional specialization of human circulating CD16 and CD1c myeloid dendritic-cell subsets","volume":"109","author":"Piccioli","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.clim.2024.110170_bb0095","series-title":"CD141 1 Dendritic Cells Produce Prominent Amounts of IFN- a After dsRNA Recognition And Can be Targeted via DEC-205 In Humanized Mice","first-page":"5034","volume":"121","author":"Meixlsperger","year":"2013"},{"key":"10.1016\/j.clim.2024.110170_bb0100","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.4049\/jimmunol.1600193","article-title":"Human blood CD1c+ dendritic cells encompass CD5high and CD5low subsets that differ significantly in phenotype, gene expression, and functions","volume":"198","author":"Yin","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2024.110170_bb0105","article-title":"Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes and progenitors","volume":"80","author":"Villani","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.clim.2024.110170_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2016.01296","article-title":"How rheumatoid arthritis can result from provocation of the immune system by microorganisms and viruses","volume":"7","author":"Arleevskaya","year":"2016","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.clim.2024.110170_bb0115","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1136\/ard.2010.128637","article-title":"High disease activity is associated with an increased risk of infection in patients with rheumatoid arthritis","volume":"70","author":"Au","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2024.110170_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fped.2022.917731","article-title":"Are infections in children with juvenile idiopathic arthritis more frequent than in healthy children? A prospective multicenter observational study","volume":"10","author":"Udaondo","year":"2022","journal-title":"Front. Pediatr."},{"issue":"2","key":"10.1016\/j.clim.2024.110170_bb0125","first-page":"390","article-title":"International league of associations for rheumatology classification of juvenile idiopathic arthritis, 2001 Edmonton","volume":"31","author":"Petty","year":"2004","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.clim.2024.110170_bb0130","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/art.24516","article-title":"Development and validation of a composite disease activity score for juvenile idiopathic arthritis","volume":"61","author":"Consolaro","year":"2009","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.clim.2024.110170_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cpz1.90","article-title":"Gene set knowledge discovery with Enrichr","volume":"1","author":"Xie","year":"2021","journal-title":"Curr Protoc."},{"key":"10.1016\/j.clim.2024.110170_bb0140","doi-asserted-by":"crossref","first-page":"W90","DOI":"10.1093\/nar\/gkw377","article-title":"Enrichr: a comprehensive gene set enrichment analysis web server 2016 update","volume":"44","author":"Kuleshov","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.clim.2024.110170_bb0145","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1365-3083.2006.01736.x","article-title":"In vitro-generated viral double-stranded RNA in contrast to polyinosinic: Polycytidylic acid induces interferon-\u03b1 in human plasmacytoid dendritic cells","volume":"63","author":"L\u00f6seke","year":"2006","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.clim.2024.110170_bb0150","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.3324\/haematol.2018.201673","article-title":"Lymphoproliferation, immunodeficiency and early-onset inflammatory bowel disease associated with a novel mutation in caspase 8 Caspase-8","volume":"103","author":"Kanderova","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.clim.2024.110170_bb0155","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/s41577-019-0224-6","article-title":"TIM3 comes of age as an inhibitory receptor","volume":"20","author":"Wolf","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.clim.2024.110170_bb0160","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/ni.2376","article-title":"Tumor-infiltrating DCs suppress nucleic acid\u2013mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1","volume":"13","author":"Chiba","year":"2012","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2024.110170_bb0165","first-page":"370","article-title":"Inborn errors of type I IFN immunity in patients with life-threatening COVID-19","volume":"80","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.clim.2024.110170_bb0170","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jaut.2018.08.003","article-title":"Interferon alpha: The key trigger of type 1 diabetes","volume":"94","author":"Lombardi","year":"2018","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.clim.2024.110170_bb0175","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nature03464","article-title":"IRF-7 is the master regulator of type-I interferon-dependent immune responses Kenya","volume":"434","author":"Honda","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.clim.2024.110170_bb0180","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.immuni.2021.04.019","article-title":"The inhibitory receptor TIM-3 limits activation of the cGAS-STING pathway in intra-tumoral dendritic cells by suppressing extracellular DNA uptake","volume":"54","author":"de Mingo","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2024.110170_bb0185","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/ni.2396","article-title":"Tumor immunity times out: TIM-3 and HMGB1 Daolin","volume":"13","author":"Daolin Tang","year":"2012","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2024.110170_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-019-1917-0","article-title":"TNF-\u03b1-induced Tim-3 expression marks the dysfunction of infiltrating natural killer cells in human esophageal cancer","volume":"17","author":"Zheng","year":"2019","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.clim.2024.110170_bb0195","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.immuni.2019.08.008","article-title":"Single-cell analysis of human mononuclear phagocytes reveals subset-defining markers and identifies circulating inflammatory dendritic cells","volume":"51","author":"Dutertre","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2024.110170_bb0200","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/9634073","article-title":"Expanded CD1c+CD163+DC3 population in synovial tissues is associated with disease progression of osteoarthritis","volume":"2022","author":"Qiu","year":"2022","journal-title":"J Immunol Res"},{"key":"10.1016\/j.clim.2024.110170_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.ppat.1007390","article-title":"Toll-like receptor 4 in acute viral infection: too much of a good thing","volume":"14","author":"Olejnik","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.clim.2024.110170_bb0210","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8874339","article-title":"COVID-19 and toll-like receptor 4 (TLR4): SARS-CoV-2 may bind and activate TLR4 to increase ACE2 expression, facilitating entry and causing Hyperinflammation","volume":"2021","author":"Aboudounya","year":"2021","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.clim.2024.110170_bb0215","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1002\/eji.200838362","article-title":"Arthritogenic dsRNA is present in synovial fluid from rheumatoid arthritis patients with an erosive disease course","volume":"38","author":"Bokarewa","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.clim.2024.110170_bb0220","first-page":"12","article-title":"Neutrophils in the pathogenesis of rheumatoid arthritis and systemic lupus erythematosus: same foe different M.O","author":"Fresneda Alarcon","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2024.110170_bb0225","first-page":"1","article-title":"Disharmonic Inflammatory Signatures in COVID-19","volume":"2","author":"Parackova","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.clim.2024.110170_bb0230","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nrrheum.2009.279","article-title":"Tumor necrosis factor blockade and the risk of viral infection","volume":"6","author":"Kim","year":"2010","journal-title":"Nat. Rev. Rheumatol."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661624000615?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661624000615?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:03:20Z","timestamp":1778616200000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661624000615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":46,"alternative-id":["S1521661624000615"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2024.110170","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor-necrosis factor \u03b1-rich environment alters type-I interferon response to viral stimuli in patients with juvenile idiopathic arthritis by altering myeloid dendritic cell phenotype","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2024.110170","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110170"}}